Lv6
1960 积分 2022-09-28 加入
The evolving landscape of drug targets
1个月前
已完结
Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy
4个月前
已完结
Discovery and development of bispecific antibodies
5个月前
已完结
Handling S/MAR Vectors
5个月前
已完结
Cost-effective yet high-performance ionizable lipids for mRNA-lipid nanoparticle vaccines
7个月前
已完结
Cost-effective yet high-performance ionizable lipids for mRNA-lipid nanoparticle vaccines
7个月前
已完结
Identification and Validation of Gene Markers for Early Detection and Prognosis in Colorectal Cancer: A Comprehensive RNA-Seq Based Approach
8个月前
已完结
Non-viral vectors for chimeric antigen receptor immunotherapy
10个月前
已完结
RNA stability enhancers for durable base-modified mRNA therapeutics
11个月前
已完结
Engineering circular RNA with Tetrahymena group I intron ribozyme
11个月前
已完结
皖公网安备34019202002308
